Superstring Capital Management LP Cytokinetics Inc Transaction History
Superstring Capital Management LP
- $115 Billion
- Q4 2024
A detailed history of Superstring Capital Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Superstring Capital Management LP holds 129,389 shares of CYTK stock, worth $5.56 Million. This represents 5.27% of its overall portfolio holdings.
Number of Shares
129,389
Previous 215,798
40.04%
Holding current value
$5.56 Million
Previous $11.4 Billion
46.58%
% of portfolio
5.27%
Previous 9.97%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
114MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$631 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$512 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$462 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$265 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$122 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.05B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...